T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44)

Funding Agency:
National Institutes of Health

The involvement of small businesses in translational aging research could substantially hasten the pace at which scientific advances are transformed into commercial products to improve or maintain the health and functional independence of older adults.  Therefore, this funding opportunity announcement (FOA) is intended to encourage a greater involvement by small businesses through the SBIR mechanism  in transforming scientific advances in aging research into novel devices, products, health care practices and programs that will benefit the lives of older adults.

For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical or basic behavioral and social research findings towards the development of new strategies for prevention and treatment of age-related pathologies. T1 translational research approaches could include the development of new research tools or improving existing technologies to diagnose, prevent or treat age-related conditions, functional decline and disability.   


  • Letter of Intent Deadlines: 30 days before application due date 
  • SBIR/STTR Deadlines: Jan. 5, Apr. 5, Sep. 5

PAR-18-183 Expiration Date September 6, 2019

Agency Website

Eligibility Requirements

Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

Amount Description

Budgets up to $225,000 total costs per year for Phase I and up to $1,500,000 total costs per year for Phase II may be requested. 

Durations up to 2 years for Phase I and up to 3 years for Phase II may be requested.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 5, 2019